Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine
Protein Science · 2023
DOI: 10.1002/pro.4619 ↗At a glance
Journal article in Protein Science, 2023. Written by Carmen Fernández-Rodríguez and 7 co-authors. Institution: Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain. Major MEDLINE topics: Cystathionine gamma-Lyase, Toxoplasma. Cited 11 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ministry of Economy and Competitiveness.
Abstract (original language)
Cystathionine γ‐lyase (CGL) is a PLP‐dependent enzyme that catalyzes the last step of the reverse transsulfuration route for endogenous cysteine biosynthesis. The canonical CGL‐catalyzed process consists of an α,γ‐elimination reaction that breaks down cystathionine into cysteine, α‐ketobutyrate, and ammonia. In some species, the enzyme can alternatively use cysteine as a substrate, resulting in the production of hydrogen sulfide (H 2 S). Importantly, inhibition of the enzyme and consequently of its H 2 S production activity, makes multiresistant bacteria considerably more susceptible to antibiotics. Other organisms, such as Toxoplasma gondii , the causative agent of toxoplasmosis, encode a CGL enzyme ( Tg CGL) that almost exclusively catalyzes the canonical process, with only minor reactivity to cysteine. Interestingly, the substitution of N360 by a serine (the equivalent amino acid residue in the human enzyme) at the active site changes the specificity of Tg CGL for the catalysis of cystathionine, resulting in an enzyme that can cleave both the CγS and the CβS bond of cystathionine. Based on these findings and to deepen the molecular basis underlying the enzyme‐substrate specificity, we have elucidated the crystal structures of native Tg CGL and the variant Tg CGL‐N360S from crystals grown in the presence of cystathionine, cysteine, and the inhibitor d , l ‐propargylglycine (PPG). Our structures reveal the binding mode of each molecule within the catalytic cavity and help explain the inhibitory behavior of cysteine and PPG. A specific inhibitory mechanism of Tg CGL by PPG is proposed.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
- Department of Biotechnology, University of Verona, Verona, Italy.
- TEKNIKER, Basque Research and Technology Alliance (BRTA), Eibar, Gipuzkoa, Spain.
ORCID profiles: Carolina Conter, Alessandra Astegno, Luis Alfonso Martínez-Cruz
Funding
- Ministry of Economy and Competitiveness
Cite
APA
Fernández-Rodríguez, C., Conter, C., Oyenarte, I., Favretto, F., Quintana, I., Martinez-Chantar, M. L., Astegno, A., & Martínez-Cruz, L. A. (2023). Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine. Protein Science. https://doi.org/10.1002/pro.4619
Vancouver
Fernández-Rodríguez C, Conter C, Oyenarte I, Favretto F, Quintana I, Martinez-Chantar ML, et al. Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine. Protein Science. 2023. doi:10.1002/pro.4619
BibTeX
@article{FernndezRodrguez2023,
author = {Fernández-Rodríguez, Carmen and Conter, Carolina and Oyenarte, Iker and Favretto, Filippo and Quintana, Iban and Martinez-Chantar, Maria Luz and Astegno, Alessandra and Martínez-Cruz, Luis Alfonso},
title = {Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine},
journal = {Protein Science},
year = {2023},
doi = {10.1002/pro.4619}
}
EUVIMED